1.Pylayeva-Gupta,Y.Grabocka,E & Bar-Sagi, D. RAS oncogenes: weaving a tumorigenic web. Nat. Rev. Cancer 11, 761-774 (2011).2. Li,S. Balmain, A. & Counter, C.M. A model for RAS mutation patterns in cancers: finding the sweet sopt. Nat. Rev. Cancer 18, 767-777 (2018).3. Lito, P.,Solomon, M., Li, L.S., et al. Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanims. Science 351, 604-608 (2016).4. Simanshu, D.K., Nissley, D.V. & McMormick, F. RAS proteins and their regulators in human disease. Cell 170, 17-33 (2017).5. Ostrem, J.M., Peters, U., Sos, M.L., et al. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503, 548-551 (2013).6. Patricelli, M.P, et al. Selective inhibition of oncogenic KRAS output with small molecules targeting the inacitve state. Cancer Discov. 6, 316-329 (2016).